HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Absence of a relationship between endometriosis and the N314D polymorphism of galactose-1-phosphate uridyl transferase in a UK population.

Abstract
An association between the N314D polymorphism of galactose-1-phosphate uridyl transferase and endometriosis has recently been reported in a North American population. To determine whether such an association exists in the UK population, we genotyped 148 women with sporadic (n = 91) or familial (n = 57) endometriosis, a control population of 95 male blood donors and a control group of 53 women with a normal pelvis at hysterectomy. Heterozygosity for the polymorphism was found in 14.9% (22/148) of affected women, 13.7% (13/95) of male blood donors and 11.3% (6/53) of women with a normal pelvis. There was no statistically significant difference in the frequency of the polymorphism between cases and controls in the UK population, even when the cases were divided into groups of moderate-severe disease, sporadic cases or familial cases. We conclude that the galactose-1-phosphate uridyl transferase N314D polymorphism is unlikely to be associated with endometriosis in the UK population.
AuthorsR M Hadfield, S Manek, S Nakago, S Mukherjee, D E Weeks, H J Mardon, D H Barlow, S H Kennedy
JournalMolecular human reproduction (Mol Hum Reprod) Vol. 5 Issue 10 Pg. 990-3 (Oct 1999) ISSN: 1360-9947 [Print] England
PMID10508229 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • UDPglucose-Hexose-1-Phosphate Uridylyltransferase
Topics
  • Adult
  • Amino Acid Substitution
  • Case-Control Studies
  • Endometriosis (enzymology, genetics)
  • Female
  • Gene Frequency
  • Genotype
  • Heterozygote
  • Humans
  • Male
  • Middle Aged
  • Polymorphism, Genetic
  • UDPglucose-Hexose-1-Phosphate Uridylyltransferase (genetics)
  • United Kingdom

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: